Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Clancy, IE
Dermot Clancy, Manorhamilton IE
| Patent application number | Description | Published |
|---|---|---|
| 20090235925 | AEROSOLISATION SYSTEM - The invention provides a combination of a micro pump | 09-24-2009 |
| 20100078013 | NEBULISER SYSTEM - A nebuliser | 04-01-2010 |
Dermot Joseph Clancy, Manorhamilton IE
| Patent application number | Description | Published |
|---|---|---|
| 20080236577 | Humidification in Breathing Circuits - A method for humidifying gas in a ventilator circuit | 10-02-2008 |
| 20090241948 | HUMIDIFICATION IN BREATHING CIRCUITS - A method for humidifying gas in a ventilator circuit | 10-01-2009 |
Maurice Joseph Anthony Clancy, Dublin IE
| Patent application number | Description | Published |
|---|---|---|
| 20080248123 | Nanoparticulate anticonvulsant and immunosuppressive compositions - Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel compositions release the agent following administration for a time period ranging from about 2 to about 24 hours or longer. | 10-09-2008 |
| 20090297619 | NANOPARTICULATE ANTICONVULSANT AND IMMUNOSUPPRESSIVE COMPOSITIONS - Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel compositions release the agent following administration for a time period ranging from about 2 to about 24 hours or longer. | 12-03-2009 |
Maurice Joseph Anthony Clancy, Booterstown IE
| Patent application number | Description | Published |
|---|---|---|
| 20080213371 | Rapidly disintegrating solid oral dosage form - Disclosed is a rapidly disintegrating solid oral dosage form of a poorly soluble active ingredient and at least one pharmaceutically acceptable water-soluble or water dispersible excipient, wherein the poorly soluble active ingredient particles have an average diameter, prior to inclusion in the dosage form, of less than about 2000 nm. The dosage form of the invention has the advantage of combining rapid presentation and rapid dissolution of the active ingredient in the oral cavity. | 09-04-2008 |
| 20090130213 | Rapidly disintegrating solid oral dosage form - Disclosed is a rapidly disintegrating solid oral dosage form of a poorly soluble active ingredient and at least one pharmaceutically acceptable water-soluble or water dispersible excipient, wherein the poorly soluble active ingredient particles have an average diameter, prior to inclusion in the dosage form, or less than about 2000 nm. The dosage form of the invention has the advantage of combining rapid presentation and rapid dissolution of the active ingredient in the oral cavity. | 05-21-2009 |
Maurice Joseph Anthony Clancy, Celbridge IE
| Patent application number | Description | Published |
|---|---|---|
| 20110300210 | CONTROLLED RELEASE NANOPARTICULATE CLOZAPINE COMPOSITIONS - Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel compositions release the agent following administration for a time period ranging from about 2 to about 24 hours or longer. | 12-08-2011 |
Maurice Joseph Anthony Clancy, Cellbridge IE
| Patent application number | Description | Published |
|---|---|---|
| 20100119611 | Delivery of a Bioactive Material - A solid pharmaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in which solid particles of the bioactive material are dispersed and encapsulated in the continuous solid phase of the encapsulating material, wherein each of the bioactive material and the encapsulating material is normally a solid at room temperature and the melting point of the encapsulating material is lower than the melting point of the bioactive material, the bioactive material being preferably a bisphosphonate, most preferably alendronate, and the encapsulating material includes an enhancer, preferably a mono- or di-glyceride, or an encapsulating surfactant, preferably a polyoxyethylene/polyoxypropylene block copolymer having surface active properties, and a process for preparing the composition in which solid particles of the bioactive material are mixed with and dispersed in the encapsulating material which is in molten (liquid) form; and cooling the molten form of the encapsulating material to form a solid pharmaceutical composition having the solid particles of the bioactive material dispersed and encapsulated in a continuous solid phase of the encapsulating material. | 05-13-2010 |
Michael S. Clancy, Monaleen IE
| Patent application number | Description | Published |
|---|---|---|
| 20100317963 | ENDOSCOPIC ULTRASOUND-GUIDED STENT PLACEMENT DEVICE AND METHOD - A system and method for ultrasound-guided placement of a stent are provided. The system includes an echogenic cannula element that may include an echogenically-enhanced cannula that may be embodied as a piercing-tipped needle and/or an echogenically-enhanced stylet, where an echogenically-enhanced cannula element portion is near the distal cannula end. A stent is disposed about the echogenically-enhanced cannula element portion, such that the stent can be navigated to a target site using ultrasound imaging of the echogenically-enhanced cannula element portion. | 12-16-2010 |
Paul Clancy, Waterford City IE
| Patent application number | Description | Published |
|---|---|---|
| 20110283997 | DOSE COUNTERS FOR INHALERS, INHALERS AND METHODS OF ASSEMBLY THEREOF - A manually operated metered dose inhaler includes a dose counter chamber including a dose display tape driven by a ratchet wheel which is driven in turn by an actuator pawl actuated by movement of a canister, the tape unwinding from a stock bobbin during use of the inhaler, a rotation regulator being provided for the stock bobbin and including a wavelike engagement surface with concavities which engage against control elements in the form of protrusions on resilient forks of a split pin thereby permitting incremental unwinding of the stock bobbin yet resisting excessive rotation if the inhaler is dropped onto a hard surface. | 11-24-2011 |